In humans gastric inhibitory polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are the only known insulin stimulating incretin hormones and are released from intestinal cells after food intake 2,3,4,5
Converting it to an injectable solution requires bacteriostatic water and careful technique
The expression levels of ABCA1 and ATP-binding cassette G1 (ABCG1) can also be increased by GLP-1, which inhibits the transformation process of macrophages into foam cells and reduces the level of intracellular cholesterol
There are no known dangerous interactions, but the blood-sugar-lowering effects of chromium, fenugreek, and white mulberry leaf could theoretically enhance the glucose-lowering effects of GLP-1 medications
Weight loss starts accelerating
Metabolic health matters too